1Suppliers
0Customers
3Debt Items
13Related Chains

Cogent Biosciences, Inc. Suppliers

TickerNameConfidenceEvidence
PLEXXIKON PLEXXIKON 92% Under the terms of the License Agreement, the Company is required to pay Plexxikon Inc., a member of the Daiichi Sankyo Group, aggregate payments of up to $ 7.5 million upon the satisfaction of certa…

Cogent Biosciences, Inc. Customers

No clients on recordNo downstream customers found in our database for Cogent Biosciences, Inc..

Cogent Biosciences, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
COGT-DEBT-8783 Warrants outstanding: 3030302 90% xbrl warrant detail from xbrl 2025-12-31.
COGT-DEBT Debt stack $238.7M 90% Market cache reports total debt of $238.7M.
COGT-DEBT-8784 Xbrl Convertible 90% xbrl convertible detail from xbrl 2018-12-31.

Cogent Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Cogent Biosciences, Inc..

Cogent Biosciences, Inc. Ownership

HolderNameConfidenceEvidence
COGT-OWNER-FMR-LLC FMR LLC 90% 13F overlay lists FMR LLC as top holder; 309 tracked holders.

Cogent Biosciences, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SABS SAB Biotherapeutics, Inc. 100.00 2
RXRX Recursion Pharmaceuticals, Inc. 100.00 2
CRSP CRISPR Therapeutics AG 100.00 2
GSK GSK plc 100.00 2
TPST Tempest Therapeutics, Inc. 100.00 2
SABSW SAB Biotherapeutics, Inc. 50.00 2
TARA Protara Therapeutics, Inc. 50.00 2
CNSP CNS Pharmaceuticals, Inc. 50.00 2
CGON CG Oncology, Inc. 50.00 2
PSTV Plus Therapeutics, Inc. 50.00 2
BDRX Biodexa Pharmaceuticals Plc 36.29 1 ['spend']
SLN Silence Therapeutics plc 14.78 2
MANU Manchester 14.78 2